FDA ends Unapproved Drugs Initiative

The FDA is ending the Unapproved Drugs Initiative, which was created in 2006 to reduce the number of drugs on the market that didn't go through the FDA approval process.

The agency said the initiative had unintended consequences, such as raising drug costs and creating more shortages. By ending it, the FDA said it believes it will prevent drugmakers from creating monopolies on older drugs and protect Americans from drug price increases and shortages.